5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(TRIPHENYLMETHYL)-AMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL
Compound with spectra: 1 NMR
![5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(TRIPHENYLMETHYL)-AMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL](/api/compound/GYSaBZzc0Bo.png?ph=true&h=300&w=458 "5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(TRIPHENYLMETHYL)-AMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL")
| SpectraBase Compound ID | GYSaBZzc0Bo |
|---|---|
| InChI | InChI=1S/C32H25ClF3NO/c33-27-18-19-29(28(22-27)30(38,32(34,35)36)21-20-23-16-17-23)37-31(24-10-4-1-5-11-24,25-12-6-2-7-13-25)26-14-8-3-9-15-26/h1-15,18-19,22-23,37-38H,16-17H2/t30-/m0/s1 |
| InChIKey | CKSURBJTVBMZGR-PMERELPUSA-N |
| Mol Weight | 532.0 g/mol |
| Molecular Formula | C32H25ClF3NO |
| Exact Mass | 531.157677 g/mol |
| Enantiomer InChIKey | CKSURBJTVBMZGR-SSEXGKCCSA-N |
| Racemate InChIKey | CKSURBJTVBMZGR-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(S)-5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(3,4-DIMETHOXYPHENYL)-METHYLAMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL
4-(4,4-Diphenyl-1,4-dihydro-2H-3,1-benzoxazin-2-yl)-N,N-diethylaniline
2-[2-(5-methyl-2-furanyl)ethyl]-4,4-diphenyl-1,2-dihydro-3,1-benzoxazine
2,2-Diphenyl-5-hydroxyindol-3-one
3-Hydroxy-1-methyl-3-(7-phenylhepta-1,6-diynyl)indolin-2-one
2-(4-Fluoro-phenyl)-4,4-diphenyl-1,4-dihydro-2H-benzo[d][1,3]oxazine
4-(4,4-diphenyl-2,4-dihydro-1H-3,1-benzoxazin-2-yl)phenol
3-Hydroxy-1-methyl-3-(7-(trimethylsilyl)hepta-1,6-diynyl)indolin-2-one
Quinazoline, 3,4-dihydro-4,4-diphenyl-2-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-
2-Deuterio-1,2,3,4-Tetrahydro-2,4-diphenyl-6-quinoline
| Title | Journal or Book | Year |
|---|---|---|
| Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor | The Journal of Organic Chemistry | 1998 |